Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Am J Hematol. 2014 Nov 19;90(2):120–124. doi: 10.1002/ajh.23886

TABLE II.

Responses (N =36 Evaluable)

N ORR (%) CR (%) CRp (%) PR (%) MLF (%)
All patients 36 14 (39) 10 (28) 3 (8) 1 (3) 3 (8)
B-ALL 24 7 (29) 4 (17) 3 (13) 3 (13)
T-ALL 8 3 (38) 3 (38)
T-LL 3 3 (100) 2 (67) 1 (33)
CML-LBP 1 1 (100) 1 (100)
Philadelphia positive 6 4 (67) 3 (50) 1 (17)
First salvage 11 4 (36) 3 (27) 1 (9) 1 (9)
Second salvage 14 4 (29) 4 (29) 2 (14)
Third+ salvage 11 5 (45) 2 (18) 3 (27)

N: number of patients; CR: complete remission; CRp: CR with incomplete platelet recovery; PR: partial remission; MLF: morphologic leukemia free; ORR: overall response rate, equals CR +CRp +PR; ALL: acute lymphoblastic leukemia; LL: lymphoblastic lymphoma; CML-LBP: chronic myelogenous leukemia-lymphoid blast phase.